The solution to Anti-Microbial Resistance (AMR) is widely thought to lie in the development of new antibiotics and diagnostic tests however Helen Lambert disagrees
Crawford Healthcare’s Richard Anderson discusses how new approaches to antimicrobial resistance and silver-based wound dressings could relieve the burden on the NHS
The European Federation of Pharmaceutical Industries and Associations discusses the importance of its Partners in Research initiative to boost research in healthcare
Without competent researchers, innovation processes in European medicines development will not be sustainable, say Klaus Wassermann and Christa Janko, EMTRAIN
Following Turing Pharmaceuticals’ famous 5,000% price hike on critical drug Daraprim, Canadian pharma group Valeant has followed up with a similarly incredulous move
Dr David Roblin, chief operating officer and director of scientific translation at the Francis Crick Institute in London, talks to EPM about the Institute’s recent partnership with GSK that will address a number of disease areas
